Predictive Markers in Lung Cancer

2012 ◽  
pp. 43-68
Author(s):  
Stephen V. Liu ◽  
Barbara J. Gitlitz
Keyword(s):  
Lung Cancer ◽  
Predictive Markers

scholarly journals Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early-Stage Non-small Cell Lung Cancer

2009 ◽  
Vol 4 (7) ◽  
pp. 891-910 ◽  
Author(s):  
Ana Belén Custodio ◽  
José Luis González-Larriba ◽  
Jana Bobokova ◽  
Antonio Calles ◽  
Rafael Álvarez ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Adjuvant Chemotherapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Early Stage ◽  
Small Cell ◽  
Predictive Markers ◽  
Small Cell Lung ◽  
Prognostic And Predictive Markers

P44.01 Clinical Predictive Markers of Response to Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC)

2021 ◽  
Vol 16 (10) ◽  
pp. S1083
Author(s):  
R. Rhone ◽  
L. Raez ◽  
K. Dumais ◽  
H. Powery ◽  
F. Gentile
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Predictive Markers ◽  
Small Cell Lung

scholarly journals Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Wolfgang M. Brueckl ◽  
Joachim H. Ficker ◽  
Gloria Zeitler
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Genetic Markers ◽  
Cell Lung Cancer ◽  
Immune Checkpoint ◽  
Palliative Treatment ◽  
Small Cell ◽  
Predictive Markers ◽  
Small Cell Lung ◽  
Prognostic And Predictive Markers

Abstract Background Immune checkpoint inhibitors (ICI) either alone or in combination with chemotherapy have expanded our choice of agents for the palliative treatment of non-small cell lung cancer (NSCLC) patients. Unfortunately, not all patients will experience favorable response to treatment with ICI and may even suffer from severe side effects. Therefore, prognostic and predictive markers, beyond programmed death ligand 1 (PD-L1) expression status, are of utmost importance for decision making in the palliative treatment. This review focuses on clinical, laboratory and genetic markers, most of them easily to obtain in the daily clinical practice. Results Recently, a number of prognostic and predictive factors in association to palliative ICI therapy have been described in NSCLC. Besides biometric parameters and clinical characteristics of the tumor, there are useful markers from routine blood sampling as well as innovative soluble genetic markers which can be determined before and during ICI treatment. Additionally, the level of evidence is noted. Conclusions These factors can be helpful to predict patients’ outcome and tumor response to ICI. They should be implemented prospectively in ICI based clinical trials to develop reliable algorithms for palliative NSCLC treatment.

scholarly journals Tumor Endothelial Markers (TEMS) as Prognostic and Predictive Markers in Non-Small Cell Lung Cancer (NSCLC)

2012 ◽  
Vol 23 ◽  
pp. ix76
Author(s):  
A. Pircher ◽  
G. Untergasser ◽  
I.M. Heidegger ◽  
J. Kern ◽  
E. Gunsilius ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Predictive Markers ◽  
Small Cell Lung ◽  
Endothelial Markers ◽  
Prognostic And Predictive Markers

Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis

Lung Cancer ◽  
2015 ◽  
Vol 88 (3) ◽  
pp. 246-253 ◽  
Author(s):  
Ying Wu ◽  
Hongbing Liu ◽  
Xuefei Shi ◽  
Yong Song
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Meta Analysis ◽  
Small Cell ◽  
Predictive Markers ◽  
Egfr Mutations ◽  
Small Cell Lung

A comparison of three clinical factors as predictive markers for response to immunotherapy in non-small cell lung cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e21158-e21158
Author(s):  
Isabel Ruth Preeshagul ◽  
Kevin M. Sullivan ◽  
Doru Paul ◽  
Robert G. Maki ◽  
Nagashree Seetharamu
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Predictive Markers ◽  
Clinical Factors ◽  
Small Cell Lung

Cytokines and chemokines as predictive markers in non-small cell lung cancer patients with brain metastases

Lung Cancer ◽  
2005 ◽  
Vol 47 (2) ◽  
pp. 291-292 ◽  
Author(s):  
Ozden Altundag ◽  
Kadri Altundag ◽  
Paolo Morandi ◽  
Mehmet Gunduz
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Predictive Markers ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Cytokines And Chemokines

scholarly journals Gefitinib in lung cancer therapy: Clinical results, predictive markers of response and future perspectives

2009 ◽  
Vol 8 (3) ◽  
pp. 206-212 ◽  
Author(s):  
Vincenzo Adamo ◽  
Tindara Franchina ◽  
Barbara Adamo ◽  
Nerina Denaro ◽  
Pietro Gambadauro ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Therapy ◽  
Clinical Results ◽  
Predictive Markers ◽  
Future Perspectives ◽  
Lung Cancer Therapy
Sign in / Sign up

Export Citation Format

Share Document